Sign in to view content

Patients Ultra-Responsive to Ranibizumab (RBZ): Rates of >4-Step Improvement in Diabetic Retinopathy Severity in DRCR.net Protocol S

Allen Chiang, MD, FASRS

Video
Published 2019

Related

Effects of Time Since Diagnosis to Intravitreal Aflibercept Injection and Baseline BCVA on Outcomes in CRVO: Post Hoc Analysis of the COPERNICUS and GALILEO Trials
Dilsher S. Dhoot, MD
Annual Meeting Talks
2022
Episode 201: AMD Drug Updates with Dr. Allen Ho, including Gene Therapy
Jayanth Sridhar, MD
Member Podcasts
2019
Episode 22: Stroke Risk in Patients with CRAO with Dr. Matthew Schrag
Keyvan Koushan, MD, FRCSC
Member Podcasts
2019

Category: Diabetic Retinopathy

See more